Bio-Rad Laboratories BIO Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories's accounts payable?
- Bio-Rad Laboratories (BIO) reported accounts payable of $133.1M in Q1 2026.
- How has Bio-Rad Laboratories's accounts payable changed year-over-year?
- Bio-Rad Laboratories's accounts payable decreased by 3.5% year-over-year, from $137.9M to $133.1M.
- What is the long-term trend for Bio-Rad Laboratories's accounts payable?
- Over 5 years (2020 to 2025), Bio-Rad Laboratories's accounts payable has grown at a -1.5% compound annual growth rate (CAGR), from $139.45M to $129M.
- What does accounts payable mean?
- Money the company owes to its suppliers for goods or services already received.
- How do you interpret accounts payable?
- An increase can signal improved cash flow management through extended payment terms, whereas a decrease may indicate faster payments or reduced purchasing activity.
- How does accounts payable compare across companies?
- Standard across all manufacturing and diagnostics companies; benchmarked against days payable outstanding.